Consolidated Balance Sheets - USD ($) $ in Millions	Oct. 29, 2023	Jan. 29, 2023
Current assets:
Cash and cash equivalents	$ 2,058	$ 2,757
Receivables, net	3,932	3,317
Merchandise inventories	22,805	24,886
Other current assets	1,887	1,511
Total current assets	30,682	32,471
Net property and equipment	25,735	25,631
Operating lease right-of-use assets	7,071	6,941
Goodwill	7,937	7,444
Other assets	4,152	3,958
Total assets	75,577	76,445
Current liabilities:
Accounts payable	11,478	11,443
Accrued salaries and related expenses	2,034	1,991
Sales taxes payable	590	528
Deferred revenue	2,784	3,064
Income taxes payable	304	50
Current installments of long-term debt	1,362	1,231
Current operating lease liabilities	1,026	945
Other accrued expenses	3,994	3,858
Total current liabilities	23,572	23,110
Long-term debt, excluding current installments	40,567	41,962
Long-term operating lease liabilities	6,300	6,226
Deferred income taxes	753	1,019
Other long-term liabilities	2,955	2,566
Total liabilities	74,147	74,883
Contingencies (Note 8)
Common stock, par value $0.05; authorized: 10,000 shares; issued: 1,796 shares at October29, 2023 and 1,794 shares at January29, 2023; outstanding: 996 shares at October29, 2023 and 1,016 shares at January29, 2023	90	90
Paid-in capital	12,927	12,592
Retained earnings	82,934	76,896
Accumulated other comprehensive loss	(662)	(718)
Treasury stock, at cost, 800 shares at October29, 2023 and 778 shares at January29, 2023	(93,859)	(87,298)
Total stockholders' equity	1,430	1,562
Total liabilities and stockholders' equity	$ 75,577	$ 76,445

Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Millions	Oct. 29, 2023	Jan. 29, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, authorized (in shares)	10,000	10,000
Common stock, issued (in shares)	1,796	1,794
Common stock, outstanding (in shares)	996	1,016
Treasury stock (in shares)	800	778

Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended	9 Months Ended
Oct. 29, 2023	Oct. 30, 2022	Oct. 29, 2023	Oct. 30, 2022
Income Statement [Abstract]
Net sales	$ 37,710	$ 38,872	$ 117,883	$ 121,572
Cost of sales	24,972	25,648	78,431	80,720
Gross profit	12,738	13,224	39,452	40,852
Operating expenses:
Selling, general and administrative	6,649	6,468	19,919	19,735
Depreciation and amortization	683	608	1,987	1,830
Total operating expenses	7,332	7,076	21,906	21,565
Operating income	5,406	6,148	17,546	19,287
Interest and other (income) expense:
Interest income and other, net	(49)	(7)	(123)	(12)
Interest expense	487	413	1,430	1,166
Interest and other, net	438	406	1,307	1,154
Earnings before provision for income taxes	4,968	5,742	16,239	18,133
Provision for income taxes	1,158	1,403	3,897	4,390
Net earnings	$ 3,810	$ 4,339	$ 12,342	$ 13,743
Basic weighted average common shares (in shares)	996	1,020	1,002	1,024
Basic earnings per share (in dollars per share)	$ 3.83	$ 4.25	$ 12.32	$ 13.42
Diluted weighted average common shares (in shares)	999	1,023	1,005	1,028
Diluted earnings per share (in dollars per share)	$ 3.81	$ 4.24	$ 12.28	$ 13.37

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended	9 Months Ended
Oct. 29, 2023	Oct. 30, 2022	Oct. 29, 2023	Oct. 30, 2022
Statement of Comprehensive Income [Abstract]
Net earnings	$ 3,810	$ 4,339	$ 12,342	$ 13,743
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(196)	(187)	51	(158)
Cash flow hedges	1	3	5	6
Total other comprehensive income (loss), net of tax	(195)	(184)	56	(152)
Comprehensive income	$ 3,615	$ 4,155	$ 12,398	$ 13,591

Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions	Total	Common Stock	Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Balance at beginning of period at Jan. 30, 2022		$ 90	$ 12,132	$ 67,580	$ (704)	$ (80,794)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock plans, net		0	(21)
Stock-based compensation expense			274
Net earnings	$ 13,743			13,743
Cash dividends				(5,856)
Foreign currency translation adjustments, net of tax	(158)				(158)
Cash flow hedges, net of tax	6				6
Repurchases of common stock	(4,994)					(4,994)
Balance at end of period at Oct. 30, 2022	1,298	90	12,385	75,467	(856)	(85,788)
Balance at beginning of period at Jul. 31, 2022		90	12,309	73,074	(672)	(84,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock plans, net		0	(2)
Stock-based compensation expense			78
Net earnings	4,339			4,339
Cash dividends				(1,946)
Foreign currency translation adjustments, net of tax	(187)				(187)
Cash flow hedges, net of tax	3				3
Repurchases of common stock	(1,224)					(1,224)
Balance at end of period at Oct. 30, 2022	1,298	90	12,385	75,467	(856)	(85,788)
Balance at beginning of period at Jan. 29, 2023	1,562	90	12,592	76,896	(718)	(87,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock plans, net		0	46
Stock-based compensation expense			289
Net earnings	12,342			12,342
Cash dividends				(6,304)
Foreign currency translation adjustments, net of tax	51				51
Cash flow hedges, net of tax	5				5
Repurchases of common stock	(6,561)					(6,561)
Balance at end of period at Oct. 29, 2023	1,430	90	12,927	82,934	(662)	(93,859)
Balance at beginning of period at Jul. 30, 2023		90	12,842	81,213	(467)	(92,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock plans, net		0	11
Stock-based compensation expense			74
Net earnings	3,810			3,810
Cash dividends				(2,089)
Foreign currency translation adjustments, net of tax	(196)				(196)
Cash flow hedges, net of tax	1				1
Repurchases of common stock	(1,516)					(1,516)
Balance at end of period at Oct. 29, 2023	$ 1,430	$ 90	$ 12,927	$ 82,934	$ (662)	$ (93,859)

Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
Oct. 29, 2023	Oct. 30, 2022
Cash Flows from Operating Activities:
Net earnings	$ 12,342	$ 13,743
Reconciliation of net earnings to net cash provided by operating activities:
Depreciation and amortization	2,415	2,216
Stock-based compensation expense	300	286
Changes in receivables, net	(538)	(312)
Changes in merchandise inventories	2,131	(3,748)
Changes in other current assets	(365)	(568)
Changes in accounts payable and accrued expenses	187	(1,568)
Changes in deferred revenue	(276)	(413)
Changes in income taxes payable	252	30
Changes in deferred income taxes	(310)	129
Other operating activities	301	226
Net cash provided by operating activities	16,439	10,021
Cash Flows from Investing Activities:
Capital expenditures	(2,368)	(2,216)
Payments for businesses acquired, net	(795)	0
Other investing activities	15	(29)
Net cash used in investing activities	(3,148)	(2,245)
Cash Flows from Financing Activities:
Repayments of short-term debt, net	0	(1,035)
Proceeds from long-term debt, net of discounts	0	6,942
Repayments of long-term debt	(1,200)	(2,423)
Repurchases of common stock	(6,465)	(5,136)
Proceeds from sales of common stock	192	146
Cash dividends	(6,304)	(5,856)
Other financing activities	(146)	(185)
Net cash used in financing activities	(13,923)	(7,547)
Change in cash and cash equivalents	(632)	229
Effect of exchange rate changes on cash and cash equivalents	(67)	(110)
Cash and cash equivalents at beginning of period	2,757	2,343
Cash and cash equivalents at end of period	2,058	2,462
Supplemental Disclosures:
Cash paid for interest, net of interest capitalized	1,504	1,160
Cash paid for income taxes	$ 3,817	$ 4,173

Describe the current financial position of your chosen company. The description must align with the company's 10-Q financial statement and include all calculations, a justification for each of the ratios used, and the following components:

net income

retained earnings

twoliquidity ratios

two solvency ratios

two profitability ratios